Stay updated on Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Sign up to get notified when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.9%
    Check dated 2025-05-28T18:20:42.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page has removed a citation related to the American Society of Clinical Oncology's guidelines for systemic therapy in stage IV non-small-cell lung cancer.
    Difference
    0.2%
    Check dated 2025-05-21T10:35:31.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page has removed a detailed citation of a clinical trial related to Cabozantinib and Sunitinib, which may affect the availability of important information regarding treatment options for metastatic renal cell carcinoma.
    Difference
    0.4%
    Check dated 2025-05-07T01:28:08.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-30T00:20:10.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed information about a clinical trial for cabozantinib in non-small cell lung cancer, while adding a new version revision and a brief mention of the CRETA trial.
    Difference
    24%
    Check dated 2025-04-22T18:13:28.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-08T09:33:42.000Z thumbnail image

Stay in the know with updates to Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.